7-134575423-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001080538.3(AKR1B15):āc.517A>Gā(p.Met173Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000706 in 1,613,794 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00045 ( 0 hom., cov: 32)
Exomes š: 0.000031 ( 1 hom. )
Consequence
AKR1B15
NM_001080538.3 missense
NM_001080538.3 missense
Scores
8
10
Clinical Significance
Conservation
PhyloP100: 3.26
Genes affected
AKR1B15 (HGNC:37281): (aldo-keto reductase family 1 member B15) Enables estradiol 17-beta-dehydrogenase activity. Predicted to be involved in estrogen biosynthetic process. Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18632525).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR1B15 | NM_001080538.3 | c.517A>G | p.Met173Val | missense_variant | 7/12 | ENST00000457545.7 | NP_001074007.2 | |
AKR1B15 | NM_001367820.1 | c.517A>G | p.Met173Val | missense_variant | 6/11 | NP_001354749.1 | ||
AKR1B15 | NM_001367821.1 | c.433A>G | p.Met145Val | missense_variant | 6/11 | NP_001354750.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKR1B15 | ENST00000457545.7 | c.517A>G | p.Met173Val | missense_variant | 7/12 | 5 | NM_001080538.3 | ENSP00000389289.1 | ||
AKR1B15 | ENST00000423958.2 | c.517A>G | p.Met173Val | missense_variant | 5/10 | 5 | ENSP00000397009.2 | |||
AKR1B15 | ENST00000652743.1 | c.433A>G | p.Met145Val | missense_variant | 5/10 | ENSP00000498877.1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
69
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000918 AC: 23AN: 250658Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135466
GnomAD3 exomes
AF:
AC:
23
AN:
250658
Hom.:
AF XY:
AC XY:
10
AN XY:
135466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461492Hom.: 1 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727058
GnomAD4 exome
AF:
AC:
45
AN:
1461492
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
727058
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000453 AC: 69AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74470
GnomAD4 genome
AF:
AC:
69
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
36
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.517A>G (p.M173V) alteration is located in exon 7 (coding exon 5) of the AKR1B15 gene. This alteration results from a A to G substitution at nucleotide position 517, causing the methionine (M) at amino acid position 173 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at